tropic
diseas
commonli
import
uk
case
report
year
death
approxim
three
quarter
report
malaria
case
uk
caus
plasmodium
falciparum
capabl
invad
high
proport
red
blood
cell
rapidli
lead
sever
lifethreaten
multiorgan
diseas
nonfalciparum
malaria
case
caus
plasmodium
vivax
case
caus
speci
plasmodium
plasmodium
oval
plasmodium
malaria
plasmodium
knowlesi
mix
infect
one
speci
parasit
occur
commonli
involv
p
falciparum
attend
risk
sever
malaria
typic
clinic
featur
malaria
even
fever
invari
present
malaria
children
sometim
adult
may
present
mislead
symptom
gastrointestin
featur
sore
throat
lower
respiratori
complaint
diagnosi
malaria
must
alway
sought
feverish
sick
child
adult
visit
malariaendem
area
specif
countri
inform
malaria
found
http
travelhealthproorguk
p
falciparum
infect
rare
present
six
month
exposur
present
speci
occur
year
exposur
manag
malaria
depend
awar
diagnosi
perform
correct
diagnost
test
diagnosi
exclud
one
blood
specimen
examin
travel
relat
infect
especi
viral
haemorrhag
fever
also
consid
optimum
diagnost
procedur
examin
thick
thin
blood
film
expert
detect
speciat
malari
parasit
p
falciparum
p
vivax
depend
upon
product
malaria
diagnos
almost
accur
use
rapid
diagnost
test
rdt
detect
plasmodi
antigen
rdt
plasmodium
speci
reliabl
patient
treat
p
falciparum
malaria
admit
hospit
least
h
patient
deterior
suddenli
especi
earli
cours
treatment
specialis
unit
see
larg
number
patient
outpati
treatment
may
consid
specif
protocol
patient
select
follow
place
uncompl
p
falciparum
malaria
treat
artemisinin
combin
therapi
grade
artemetherelumefantrin
riamet
drug
choic
grade
dihydroartemisininpiperaquin
eurartesim
altern
quinin
atovaquon
eproguanil
malaron
use
act
avail
quinin
highli
effect
poorlytoler
prolong
treatment
use
combin
addit
drug
usual
oral
doxycyclin
sever
falciparum
malaria
infect
complic
rel
high
parasit
count
red
blood
cell
parasit
treat
intraven
therapi
patient
well
enough
continu
oral
treatment
sever
malaria
rare
complic
p
vivax
p
knowlesi
infect
also
requir
parenter
therapi
treatment
choic
sever
complic
malaria
adult
children
intraven
artesun
grade
intraven
artesun
unlicens
eu
avail
mani
centr
altern
intraven
quinin
start
immedi
artesun
avail
grade
patient
treat
intraven
quinin
requir
care
monitor
hypoglycemia
patient
sever
complic
malaria
manag
highdepend
intens
care
environ
may
requir
haemodynam
support
manag
acut
respiratori
distress
syndrom
dissemin
intravascular
coagul
acut
kidney
injuri
seizur
sever
intercurr
infect
includ
gramneg
bacteraemiasepticaemia
children
sever
malaria
also
treat
empir
broad
spectrum
antibiot
bacteri
infect
exclud
grade
haemolysi
occur
approxim
patient
follow
intraven
artesun
treatment
haemoglobin
concentr
check
approxim
day
follow
treatment
treat
iv
artemisinin
grade
falciparum
malaria
pregnanc
like
complic
placenta
contain
high
level
parasit
stillbirth
earli
deliveri
may
occur
diagnosi
difficult
parasit
concentr
placenta
scanti
blood
uncompl
falciparum
malaria
second
third
trimest
pregnanc
treat
artemetherelumefantrin
grade
uncompl
falciparum
malaria
first
trimest
pregnanc
usual
treat
quinin
clindamycin
specialist
advic
sought
sever
malaria
trimest
pregnanc
treat
patient
artesun
prefer
quinin
grade
children
uncompl
malaria
treat
act
artemeth
elumefantrin
dihydroartemisininpiperaquin
first
line
treatment
grade
quinin
doxycyclin
clindamycin
atovaquoneeproguanil
appropri
dose
weight
also
use
doxycyclin
given
children
year
either
oral
act
chloroquin
use
treatment
nonfalciparum
malaria
oral
act
prefer
mix
infect
uncertainti
infect
speci
p
vivax
infect
area
chloroquin
resist
common
grade
dormant
parasit
hypnozoit
persist
liver
treatment
p
vivax
p
oval
infect
current
effect
drug
erad
hypnozoit
primaquin
primaquin
effect
prevent
relaps
taken
time
chloroquin
grade
primaquin
avoid
given
caution
expert
supervis
patient
dehydrogenas
defici
may
caus
sever
haemolysi
primaquin
erad
p
vivax
p
oval
hypnozoit
contraind
pregnanc
breastfeed
statu
child
known
initi
treatment
infect
pregnant
woman
take
weekli
chloroquin
prophylaxi
deliveri
cessat
breastfeed
hypnozoit
erad
consid
acut
attack
malaria
confer
protect
futur
attack
individu
malaria
take
effect
antimosquito
precaut
chemoprophylaxi
futur
visit
endem
area
british
infect
associ
publish
elsevi
ltd
right
reserv
malaria
remain
one
common
import
infect
unit
kingdom
uk
malaria
case
report
year
uk
although
review
report
suggest
may
repres
case
occur
approxim
threequart
report
infect
due
plasmodium
falciparum
death
annual
children
account
around
case
two
third
case
occur
peopl
african
south
asian
ethnic
origin
half
case
occur
visit
friend
famili
endem
area
patient
falciparum
malaria
acquir
infect
africa
malaria
account
travel
africa
present
hospit
fever
west
africa
commonest
geograph
sourc
plasmodium
vivax
infect
acquir
south
asia
document
offer
guidanc
manag
uncompl
complic
malaria
uk
complement
exist
public
health
england
phe
guidelin
prevent
malaria
uk
travel
http
wwwgovukgovernmentpublicationsmalariapreventionguidelinesfortravellersfromtheuk
base
review
avail
evid
phe
advisori
committe
malaria
prevent
acmp
input
expert
expert
bodi
incorpor
intern
guidanc
includ
guidelin
treatment
definit
sever
malaria
guidelin
specif
present
uk
perspect
manag
nonendem
countri
includ
usa
canada
europ
also
develop
guidelin
uk
guidelin
develop
specif
use
nonendem
set
necessarili
depend
heavili
upon
evid
obtain
studi
endem
area
detail
inform
individu
drug
regimen
contraind
found
british
nation
formulari
http
wwwbnforg
short
summari
key
point
initi
assess
manag
use
emerg
depart
avail
british
infect
associ
websit
http
wwwbritishinfectionorg
major
recommend
grade
use
modifi
grade
approach
grade
strength
recommend
level
evid
recommend
grade
recommend
strong
recommend
someth
benefit
clearli
outweigh
risk
vice
versa
patient
grade
recommend
condit
recommend
risk
benefit
close
balanc
uncertain
grade
evid
mean
highqual
evid
come
consist
result
high
qualiti
randomis
control
trial
rct
grade
b
evid
mean
moderatequ
evid
randomis
trial
suffer
flaw
conduct
design
methodolog
strong
observ
studi
consist
effect
exclus
sourc
bia
grade
c
evid
lowqual
evid
control
trial
seriou
limit
inconsist
result
observ
studi
limit
evid
effect
grade
evid
base
case
studi
expert
judgement
poor
qualiti
observ
studi
assess
patient
suspect
malaria
box
crucial
issu
manag
malaria
consider
possibl
diagnosi
malaria
suspect
anyon
fever
histori
fever
return
previous
visit
malaria
endem
area
regardless
whether
taken
prophylaxi
minimum
incub
period
natur
acquir
infect
six
day
patient
falciparum
infect
present
first
month
month
exposur
almost
present
within
six
month
exposur
vivax
oval
infect
commonli
present
later
six
month
exposur
present
may
delay
year
specif
symptom
malaria
patient
complain
fever
headach
gener
malais
gastrointestin
disturb
jaundic
respiratori
symptom
occasion
occur
often
respons
misdiagnosi
miss
malaria
infect
erron
diagnos
nonspecif
viral
infect
influenza
gastroenter
hepat
children
less
like
adult
complain
chill
arthralgiamyalgia
headach
like
present
nonspecif
symptom
fever
lethargi
malais
somnol
gastrointestin
symptom
nausea
abdomin
pain
vomit
diarrhoea
particularli
common
physic
examin
patient
uncompl
malaria
often
unremark
apart
fever
invari
present
patient
specif
fever
pattern
children
like
hepatomegali
splenomegali
somnol
adult
diagnosi
falciparum
malaria
delay
sever
ill
patient
may
present
jaundic
confus
seizur
malaria
suspect
blood
test
malaria
without
delay
mandatori
unless
rapid
malaria
test
achiev
primari
care
patient
refer
hospit
test
result
commun
day
posit
test
telephon
back
request
doctor
soon
practic
ideal
within
h
test
reach
laboratori
import
test
examin
thick
thin
blood
smear
microscopi
highli
sensit
specif
expert
hand
howev
lack
expertis
mani
uk
lab
particularli
hour
rapid
diagnost
test
rdt
base
upon
detect
parasit
antigen
commonli
use
addit
blood
slide
although
slightli
less
sensit
good
qualiti
blood
film
examin
experienc
microscopist
easier
nonexpert
use
detect
falciparum
infect
use
initi
screen
expertis
read
slide
immedi
avail
rdt
gener
specif
sensit
detect
nonfalciparum
infect
although
newer
gener
rdt
perform
well
diagnos
vivax
infect
rdt
may
use
addit
replac
blood
film
patient
suspect
malaria
blood
film
prepar
examin
recommend
british
committe
standard
haematolog
guidelin
falciparum
knowlesi
malaria
diagnos
percentag
red
blood
cell
parasit
estim
clinic
suspicion
malaria
initi
blood
film
neg
repeat
film
without
rdt
examin
h
h
rdt
use
alon
discourag
good
microscopi
avail
thrombocytopaenia
suggest
malaria
nonimmun
adult
children
nonfalciparum
malaria
p
falciparum
although
also
occur
number
import
infect
malaria
unlik
three
neg
specimen
examin
compet
microscopist
empir
therapi
malaria
given
unless
patient
convinc
exposur
histori
demonstr
featur
sever
malaria
expert
advic
taken
pregnanc
thick
film
neg
despit
presenc
parasit
placenta
expert
advic
sought
malaria
suspect
pcr
techniqu
use
refer
laboratori
determin
speci
malaria
suffici
standardis
valid
use
routin
clinic
diagnosi
case
malaria
notifi
public
health
author
england
wale
thick
thin
film
blood
aliquot
sent
malaria
refer
laboratori
confirm
perform
free
charg
scottish
parasit
diagnost
refer
laboratori
provid
refer
servic
scotland
malaria
diagnos
return
travel
member
famili
travel
group
warn
may
share
exposur
risk
seek
medic
attent
develop
symptom
malaria
particularli
sever
malaria
alway
manag
consult
someon
experienc
manag
diseas
nonfalciparum
malaria
distinct
falciparum
malaria
speci
malaria
import
malaria
caus
plasmodium
oval
p
vivax
plasmodium
malaria
rare
caus
lifethreaten
diseas
usual
manag
outpati
basi
unless
patient
comorbid
toler
oral
medic
howev
sever
present
plasmodium
knowlesi
infect
p
vivax
well
recognis
sever
p
oval
occur
except
circumst
clinician
look
rare
case
box
import
consider
assess
patient
possibl
malaria
malaria
medic
emerg
patient
suspect
malaria
evalu
immedi
symptom
malaria
often
nonspecif
feversweatschil
malais
myalgia
headach
diarrhoea
cough
falciparum
malaria
like
occur
within
month
return
endem
area
incub
period
malaria
least
day
malaria
caus
speci
may
present
year
return
endem
area
care
exposur
histori
necessari
countri
area
travel
includ
stopov
date
return
consid
malaria
prophylaxi
taken
ie
drug
dose
adher
prematur
cessat
appropri
prophylaxi
full
adher
exclud
malaria
consid
travelrel
infect
eg
typhoid
hepat
dengu
arbovirus
avian
influenza
merscov
hiv
meningitisenceph
viral
haemorrhag
fever
vhf
three
neg
diagnost
sampl
period
h
necessari
exclud
malaria
estim
haemoglobin
concentr
done
malaria
caus
p
vivax
p
oval
dehydrogenas
activ
measur
concomit
primaquin
therapi
necessari
elimin
hypnozoit
dormant
form
liver
primaquin
caus
haemolysi
patient
defici
patient
mix
infect
includ
falciparum
parasit
infect
unidentifi
speci
treat
though
falciparum
infect
first
instanc
patient
falciparum
malaria
usual
admit
hospit
initi
risk
deterior
even
effect
treatment
initi
limit
evid
patient
falciparum
malaria
manag
safe
outpati
unit
see
larg
number
patient
use
well
defin
protocol
assess
follow
certain
factor
age
ethnic
parasit
count
predict
likelihood
sever
malaria
even
patient
might
expect
semiimmun
may
deterior
rapidli
requir
intens
care
treatment
outpati
manag
malaria
adult
undertaken
clinician
experienc
manag
malaria
clear
protocol
system
assess
like
risk
sever
malaria
rapidli
reassess
patient
children
falciparum
malaria
observ
hospit
initi
least
h
possibl
rapid
progress
also
ensur
toler
oral
therapi
treatment
children
may
complic
vomit
patient
observ
close
certain
categori
pregnant
women
infant
elderli
like
develop
sever
diseas
deterior
rapidli
manag
patient
falciparum
malaria
especi
sever
alway
discuss
specialist
mortal
higher
region
uk
malaria
less
commonli
manag
uk
malaria
case
seen
centr
less
case
year
patient
falciparum
malaria
mix
infect
includ
falciparum
parasit
divid
uncompl
sever
complic
diseas
box
assess
patient
includ
care
clinic
evalu
review
investig
featur
sever
malaria
detail
full
blood
count
urea
creatinin
electrolyt
liver
function
test
blood
glucos
done
routin
thrombocytopaenia
common
isol
reflect
sever
diseas
ill
patient
blood
gase
blood
cultur
lactat
clot
studi
also
perform
urin
dipstick
cultur
stool
cultur
chest
xray
may
appropri
lumbar
punctur
exclud
mening
consid
febril
patient
impair
conscious
repeat
seizur
initi
parasit
count
help
estim
potenti
futur
sever
diseas
although
highli
depend
upon
stage
infect
red
blood
cell
parasit
increas
chanc
develop
sever
diseas
even
patient
initi
box
common
error
diagnosi
manag
malaria
adapt
beech
nj
et
al
permiss
delay
patient
present
failur
health
care
worker
take
travel
histori
consid
diagnosi
malaria
belief
chemoprophylaxi
prevent
malaria
belief
malaria
unlik
patient
rememb
bitten
mosquito
belief
malaria
present
classic
fever
pattern
failur
recognis
nonspecif
clinic
present
malaria
failur
obtain
immedi
blood
film
rdt
failur
repeat
diagnost
test
first
test
neg
failur
prescrib
adequ
appropri
chemotherapi
immedi
failur
anticip
treat
complic
impair
conscious
seizur
renal
impair
oliguria
mlkg
bodyweight
per
hour
creatinin
mmoll
acidosi
ph
hypoglycemia
mmoll
pulmonari
oedema
acut
respiratori
distress
syndrom
ard
haemoglobin
gl
spontan
bleedingdissemin
intravascular
coagul
shock
algid
malaria
e
bp
mmhg
haemoglobinuria
without
defici
parasitaemia
appear
well
parasitaemia
consid
repres
sever
diseas
import
poor
prognost
factor
presenc
peripher
blood
schizont
p
falciparum
pigment
deposit
peripher
polymorphonuclear
leucocyt
blood
film
metabol
acidosi
elev
lactat
level
older
age
coma
renal
impair
treatment
uncompl
falciparum
malaria
adult
three
main
therapeut
option
treatment
uncompl
falciparum
malaria
adult
uk
artemisinin
combin
therapi
act
oral
atovaquoneeproguanil
quinin
plu
doxycyclin
quinin
plu
clindamycin
certain
circumst
see
box
detail
dose
two
act
licenc
use
uk
artemetherelumefantrin
dihydroartemisininpiperaquin
although
mefloquin
effect
treatment
side
effect
high
rate
noncomplet
cours
mean
recommend
therapi
uk
act
highli
effect
clear
parasit
rapidli
option
effect
throughout
broader
rang
parasit
life
cycl
reason
consid
drug
choic
uncompl
malaria
grade
studi
compar
act
oral
quinin
africa
demonstr
greater
efficaci
use
act
driven
partli
poor
complianc
quinin
experi
artemetherelumefantrin
western
set
seem
well
toler
artemetherelumefantrin
ideal
taken
high
fat
meal
maximis
absorpt
consid
act
choic
grade
act
need
given
three
day
although
dha
piperaquin
dhappq
advantag
need
singl
daili
dose
concern
potenti
qtc
prolong
dhappq
data
becom
avail
recommend
dhappq
taken
h
food
patient
eat
h
dose
dhapiperaquin
prevent
excess
peak
piperaquin
level
dhappq
current
use
patient
previou
arrhythmia
cardiac
condit
predispos
arrhythmia
take
drug
prolong
qt
interv
ecg
obtain
earli
cours
treatment
dhappq
last
daili
dose
dhappq
frequent
monitor
may
indic
take
drug
inhibit
potenti
increas
piperaquin
level
clarithromycin
atovaquoneeproguanil
malaron
use
extens
western
set
high
level
efficaci
although
parasit
clearanc
rel
slow
three
day
almost
quarter
patient
experienc
gastrointestin
sideeffect
patient
warn
ensur
full
adher
contrast
three
day
regimen
act
atovaquoneeproguanil
quinin
need
taken
five
seven
day
parasit
clear
requir
daili
monitor
quinin
often
associ
cinchon
nausea
deaf
ring
ear
may
result
poor
adher
although
intern
recommend
suggest
quinin
taken
seven
day
endem
area
uk
experi
suggest
five
day
treatment
adequ
vast
major
case
combin
second
drug
doxycyclin
adult
clindamycin
pregnant
women
young
children
ensur
complet
erad
parasit
second
drug
taken
either
simultan
quinin
sequenti
quinin
view
increas
failur
rate
antifol
drug
part
world
sulfadoxinepyrimethamin
fansidar
use
routin
second
drug
accompani
quinin
except
specialist
advic
chloroquin
use
treatment
falciparum
malaria
antibiot
includ
tetracyclin
sulfa
drug
macrolid
clindamycin
use
combin
therapi
use
alon
treatment
malaria
insuffici
evid
support
use
azithromycin
either
alon
combin
drug
treatment
malaria
treatment
sever
complic
falciparum
malaria
antimalari
therapi
urgent
appropri
parenter
therapi
antimalari
greatest
impact
prognosi
sever
malaria
treatment
delay
patient
proven
strongli
suspect
malaria
parenter
treatment
indic
patient
sever
complic
malaria
high
risk
develop
sever
diseas
box
patient
vomit
unabl
take
oral
antimalari
substanti
evid
superior
intraven
artesun
intraven
quinin
two
larg
trial
metaanalysi
combin
smaller
trial
demonstr
mortal
benefit
adult
children
patient
sever
malaria
intraven
artesun
therefor
consid
treatment
choic
sever
malaria
grade
manufactur
intraven
artesun
achiev
good
manufactur
practic
gmp
certif
artesun
licenc
european
union
howev
factori
manufactur
artesun
achiev
prequalif
standard
import
artesun
also
carri
qualiti
check
import
batch
intraven
artesun
stock
mani
infecti
diseas
unit
uk
also
obtain
specialist
tropic
diseas
centr
london
liverpool
see
contact
detail
recommend
centr
regularli
see
patient
sever
malaria
stock
artesun
howev
treatment
never
delay
whilst
obtain
artesun
everi
patient
sever
malaria
start
quinin
initi
artesun
immedi
avail
delay
danger
grade
addit
benefit
use
artesun
combin
quinin
safe
follow
minimum
h
intraven
artesun
patient
improv
abl
take
oral
medic
full
cours
act
artemetherelumefantrin
dhappq
given
altern
full
cours
quinin
doxycyclin
clindamycin
children
pregnant
women
atovaquoneeproguanil
could
use
clearanc
parasit
check
daili
thick
blood
film
increas
experi
use
intraven
artesun
western
nonimmun
travel
demonstr
rapid
effect
gener
low
advers
event
rate
compar
quinin
howev
clear
emerg
evid
delay
haemolysi
day
post
treatment
follow
intraven
artesun
approxim
adult
children
especi
high
parasit
count
appear
selflimit
patient
warn
awar
potenti
symptom
anaemia
haemoglobin
level
routin
check
approxim
day
complet
artesun
grade
emerg
evid
reduc
suscept
artemisinin
deriv
se
asia
alter
current
recommend
use
artesun
first
line
therapi
region
grade
howev
case
sever
malaria
monitor
clearanc
parasit
recurr
symptom
recommend
artemeth
oilbas
intramuscular
artemisinin
prepar
produc
gmp
standard
howev
despit
gener
favour
trend
sever
studi
metaanalys
shown
clear
advantag
artemeth
quinin
manag
sever
malaria
either
adult
children
recommend
use
grade
intraven
quinin
dihydrochlorid
altern
artesun
immedi
avail
given
intraven
infus
initi
load
dose
mgkg
dextros
dextrosesalin
h
achiev
high
blood
level
rapidli
see
box
follow
mgkg
infus
h
everi
h
load
dose
given
quinin
mefloquin
therapi
taken
within
previou
h
grade
caution
exercis
older
patient
cardiac
diseas
potenti
quinin
lead
arrhythmia
patient
ecg
monitor
intraven
quinin
treatment
patient
well
enough
take
oral
medic
treatment
complet
full
cours
oral
box
indic
parenter
therapi
adult
parasitaemia
red
blood
cell
parasit
pregnant
women
follow
specialist
advic
patient
unabl
swallowretain
tablet
box
drug
treatment
sever
complic
malaria
artesun
regimen
mgkg
given
intraven
inject
h
daili
thereaft
complet
minimum
h
therapi
maximum
five
day
full
cours
oral
act
taken
patient
toler
oral
medic
quinin
load
dose
mgkg
quinin
dihydrochlorid
dextros
dextros
salin
h
follow
mgkg
everi
h
first
h
patient
swallow
frequenc
dose
reduc
hourli
intraven
quinin
continu
h
parenter
quinin
therapi
continu
patient
take
oral
therapi
quinin
sulphat
mg
given
three
time
day
complet
five
seven
day
quinin
total
quinin
treatment
alway
accompani
second
drug
doxycyclin
mg
clindamycin
mg
three
time
day
children
pregnant
women
given
oral
total
seven
day
patient
swallow
agent
box
quinin
use
total
combin
iv
oral
cours
seven
day
appropri
intraven
quinin
need
continu
longer
h
patient
renal
failur
sever
hepat
dysfunct
quinin
dose
reduc
third
neither
quinin
artesun
level
affect
haemofiltr
dose
modif
necessari
patient
sever
complic
malaria
manag
high
depend
unit
patient
may
deterior
rapidli
close
observ
vital
transfer
intens
care
unit
consid
sever
acidosi
high
lactat
level
pulmonari
oedemaacut
respiratori
distress
syndrom
complic
fluid
balanc
problem
renal
impair
deterior
despit
appropri
treatment
box
care
fluid
balanc
import
avoid
overfil
may
exacerb
increas
pulmonari
capillari
permeabl
occur
sever
malaria
grade
evid
measur
central
venou
pressur
use
predict
true
volum
statu
sever
malaria
much
lactic
acidosi
seen
sever
malaria
may
due
microvascular
obstruct
rather
hypovolaemia
hypoglycemia
may
occur
sever
malaria
complic
quinineinduc
hyperinsulinemia
may
develop
late
clinic
cours
even
patient
appear
recov
blood
glucos
level
use
stix
method
check
routin
everi
h
grade
twohourli
quinin
infus
grade
time
reduc
conscious
occur
grade
infus
dextros
may
necessari
correct
hypoglycemia
haemoglobin
clot
electrolyt
includ
calcium
sometim
magnesium
renal
function
close
monitor
frequent
parasit
count
help
earli
manag
sever
malaria
peripher
parasit
count
fluctuat
accord
stage
parasit
develop
uncommon
parasit
count
increas
first
h
treatment
indic
failur
therapi
daili
parasit
count
suffici
recommend
ensur
clearanc
patient
develop
shock
may
secondari
complic
bacteraemiasepticaemia
algid
malaria
patient
sign
shock
treat
broad
spectrum
antibiot
grade
platelet
transfus
indic
even
low
count
unless
activ
bleed
appropri
ventilatori
support
renal
replac
therapi
initi
clinic
indic
haemofiltr
appear
superior
periton
dialysi
patient
impair
conscious
coma
manag
appropri
corticosteroid
mannitol
nacetylcystein
levamisol
shown
ineffect
adjunct
therapi
treatment
sever
malaria
role
exchang
transfus
manag
sever
malaria
alway
controversi
clear
evid
benefit
potenti
risk
especi
individu
may
haemodynam
instabl
artesun
greatest
mortal
advantag
high
parasit
count
rapid
action
artesun
reduc
parasit
burden
mean
benefit
exchang
transfus
like
substanti
reduc
current
opinion
exchang
transfus
longer
indic
sever
malaria
grade
routin
blood
transfus
may
indic
symptomat
anaemia
clear
evid
risk
falciparum
vivax
malaria
lead
mortal
increas
steadili
age
elderli
patient
admit
monitor
close
malaria
pregnanc
carri
higher
risk
sever
diseas
also
associ
miscarriag
stillbirth
pregnant
women
malaria
requir
prompt
treatment
manag
collabor
obstetr
team
close
observ
hospit
includ
uterin
foetal
heart
monitor
develop
complic
necessari
earli
deliveri
nearterm
infant
risk
may
need
consid
rcog
produc
specif
guidelin
treatment
malaria
pregnanc
uncompl
falciparum
malaria
neither
artemetherelumefantrin
riamet
atovaquoneeproguanil
malaron
dhappq
licenc
pregnanc
evid
advers
effect
artemetherelumefantrin
second
third
trimest
limit
number
studi
data
safeti
first
trimest
even
limit
evid
harm
detect
small
studi
atovaquoneeproguanil
shown
evid
advers
effect
artemetherelumefantrin
consid
treatment
choic
second
third
trimest
grade
inform
dhappq
current
limit
quinin
seven
day
combin
clindamycin
see
dose
use
box
intens
care
manag
sever
complic
malaria
care
manag
fluid
balanc
optimis
oxygen
deliveri
prevent
pulmonari
oedema
regular
monitor
hypoglycemia
consid
broad
spectrum
antibiot
evid
shock
secondari
bacteri
infect
haemofiltr
renal
failur
control
acidosi
fluidelectrolyt
imbal
consid
medic
control
seizur
three
trimest
quinin
increas
risk
uterin
contract
hypoglycemia
sever
malaria
sever
malaria
pregnanc
associ
high
case
fatal
rate
pregnanc
loss
hypoglycemia
pulmonari
oedema
particularli
common
littl
publish
evid
use
safeti
intraven
artesun
pregnant
women
particularli
first
trimest
balanc
risk
artesun
prefer
quinin
basi
like
higher
effect
reduc
mortal
grade
intraven
quinin
clindamycin
altern
oral
quinin
atovaquoneeproguanil
malaron
artemetherelumefantrin
dhappq
use
treatment
uncompl
malaria
children
box
limit
experi
use
artemisinin
combin
therapi
nonendem
paediatr
popul
although
act
recommend
firstlin
treatment
uncompl
malaria
children
malaria
endem
region
despit
basi
evid
endem
area
committe
believ
act
first
line
therapi
children
uk
grade
combin
oral
quinin
seven
day
clindamycin
doxycyclin
children
greater
year
age
remain
highli
effect
uk
low
relaps
rate
children
contrast
view
author
believ
oral
quinin
usual
welltoler
children
use
treatment
uncompl
falciparum
malaria
uk
act
avail
tetracyclin
given
children
year
age
risk
dental
hypoplasia
perman
discolour
teeth
sever
complic
falciparum
malaria
children
box
main
clinic
present
sever
malaria
children
cerebr
malaria
sever
anaemia
respiratori
distressacidosi
featur
cerebr
malaria
includ
depress
consciou
level
seizur
alter
respir
postur
decort
decerebr
hypoglycemia
metabol
acidosi
circulatori
shock
electrolyt
disturb
may
also
present
prostrat
inabl
stand
sit
also
indic
sever
diseas
children
manag
sever
complic
malaria
children
involv
emerg
assess
provis
support
care
includ
respiratori
cardiovascular
support
outlin
maitland
et
al
children
sever
complic
malaria
manag
paediatr
intens
care
unit
high
depend
unit
togeth
supportadvic
paediatr
infecti
diseasestrop
medicin
specialist
experi
manag
malaria
judici
slow
volum
resuscit
import
children
present
shock
feast
trial
show
detriment
effect
routin
fluid
bolu
administr
hypoglycemia
common
complic
sever
malaria
serial
blood
glucos
estim
must
perform
hypoglycemia
correct
use
glucos
mainten
fluid
often
difficult
exclud
differenti
concurr
bacteri
septic
shock
mening
sever
malaria
empir
broad
spectrum
antibiot
given
children
sever
malaria
bacteri
infect
exclud
grade
manag
seizur
follow
evidencebas
guidelin
advoc
advanc
paediatr
life
support
group
blood
transfus
may
requir
sever
anaemia
although
cochran
review
found
routin
transfus
reduc
mortal
caus
advers
event
clear
evid
larg
randomis
trial
show
although
quinin
remain
effect
artesun
associ
surviv
advantag
rel
risk
reduct
signific
reduct
clinic
complic
develop
coma
convuls
deterior
coma
score
line
guidelin
recommend
iv
artesun
use
preferenti
quinin
drug
choic
treatment
sever
falciparum
malaria
children
grade
recent
guidelin
suggest
higher
dose
requir
children
kg
intraven
quinin
still
indic
artesun
immedi
avail
treatment
delay
whilst
await
artesun
therapi
treat
acut
infect
treatment
nonfalciparum
malaria
consist
treat
erythrocyt
asexu
form
caus
symptom
infect
p
vivax
p
oval
also
ensur
erad
liver
hypnozoit
prevent
relaps
infect
box
mix
infect
either
vivax
oval
falciparum
treat
need
addit
drug
treat
blood
form
nonfalciparum
infect
relaps
due
liver
form
still
need
prevent
either
oral
act
chloroquin
mgkg
total
day
use
treat
blood
form
nonfalciparum
speci
grade
fever
parasit
clearanc
time
faster
act
regimen
chloroquin
nonfalciparum
malaria
evid
come
studi
vivax
chloroquin
highli
effect
p
malaria
p
oval
p
knowlesi
effect
case
vivax
malaria
chloroquin
resist
lead
poor
clinic
outcom
chloroquin
treatment
recognis
vivax
malaria
sinc
uncommon
increas
problem
particularli
region
papua
new
guinea
indonesia
chloroquin
still
use
vivax
infect
region
appropri
followup
act
may
prefer
grade
act
regimen
first
line
therapi
falciparum
malaria
reliabl
exclud
treatment
mix
infect
includ
p
falciparum
also
provid
altern
individu
nonfalciparum
malaria
toler
chloroquin
case
sever
complic
nonfalciparum
malaria
treat
parenter
artesun
quinin
sever
falciparum
malaria
artesun
appear
highli
effect
sever
p
knowlesi
infect
chloroquin
safe
option
treatment
nonfalciparum
malaria
throughout
pregnanc
act
use
second
third
trimest
quinin
may
use
first
trimest
concern
resist
vivax
box
sever
complic
malaria
children
impair
conscious
seizur
respiratori
distress
acidosi
ph
hypoglycemia
mmoll
sever
anaemia
gdl
prostrat
parasitaemia
red
blood
cell
parasit
late
present
relaps
due
hypnozoit
liver
occur
patient
vivax
malaria
treat
chloroquin
alon
blood
schizonticid
chloroquin
drug
current
use
treat
acut
malaria
elimin
liver
stage
second
drug
requir
achiev
radic
cure
primaquin
drug
choic
elimin
hypnozoit
oval
vivax
malaria
grade
patient
screen
defici
primaquin
treatment
primaquin
may
caus
haemolysi
defici
individu
efficaci
primaquin
prevent
relaps
highli
depend
upon
coadministr
chloroquin
altern
drug
clear
red
cell
form
primaquin
also
intrins
activ
asexu
blood
form
p
vivax
p
oval
concomit
administr
chloroquin
boost
blood
primaquin
level
administr
two
drug
therefor
overlap
grade
centr
commonli
see
patient
vivax
malaria
system
rapid
assess
statu
set
standard
therapeut
dose
mg
primaquin
baseday
day
appropri
radic
treatment
p
oval
howev
certain
geograph
strain
p
vivax
long
recognis
less
sensit
primaquin
requir
higher
dose
primaquin
prevent
relaps
also
increas
evid
failur
standard
dose
primaquin
geograph
area
clinic
relaps
occur
uk
patient
import
vivax
treat
chloroquin
follow
unsupervis
primaquin
mg
daili
day
higher
dose
primaquin
mg
daili
mgkg
effect
mg
daili
south
asia
sourc
uk
infect
administr
primaquin
therapi
less
day
associ
higher
relaps
rate
day
regimen
therefor
recommend
vivax
malaria
primaquin
given
dose
mg
daili
day
prevent
relaps
along
treatment
chloroquin
grade
pregnant
breastfeed
women
weekli
suppress
chloroquin
prophylaxi
mg
week
given
primaquin
given
follow
deliveri
complet
breastfeed
expert
opinion
sought
treat
patient
defici
mild
moder
defici
altern
regimen
mg
mgkg
primaquin
weekli
eight
week
may
effect
safe
toler
grade
case
particularli
previous
suffer
sever
advers
effect
primaquin
may
prudent
withhold
primaquin
treatment
treat
relaps
promptli
patient
rel
provid
full
explan
condit
specif
issu
relat
therapi
includ
warn
possibl
immedi
late
complic
treatment
box
although
systemat
studi
valu
earli
followup
patient
follow
treatment
import
malaria
committe
believ
good
practic
repeat
blood
film
full
blood
count
approxim
fourteen
day
treatment
particularli
patient
sever
malaria
receiv
artemisinin
therapi
also
provid
opportun
reinforc
need
appropri
antimalari
precaut
taken
patient
rel
next
time
travel
http
wwwgovukgovern
publicationsmalariapreventionguidelinesfortravellersfromtheuk
malaria
refer
laboratori
http
wwwgovuk
governmentpublicationsmalariareferencelaboratorymrluserhandbook
scottish
parasit
diagnost
refer
laboratori
http
wwwnhsggcorgukaboutusprofessionalsupportsitesscottishmicrobiologyreferencelaboratori
scottishparasitediagnosticreferencelaboratori
hospit
tropic
diseas
uch
london
tropic
infecti
diseas
unit
royal
liverpool
univers
hospit
